Epiglottitis Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: EBFF18973CB8EN
Market Monitor Global

Abstracts

Epiglottitis is a bacterial viral infection which results in inflammation and swelling of epiglottis, basically epiglottis is a cartilage structure which located at the back of the throat, beneath the tongue and the function of epiglottis is close over the trachea when foods are being swallowed, Epiglottitis causes breathing issue, tachycardia, swelling of supraglottic tissue, inspiratory stridor, pharyngitis, cervical lymph nodes, inability to handle secretion.

This report contains market size and forecasts of Epiglottitis Drug in Global, including the following market information:

Global Epiglottitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Epiglottitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Antibiotic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epiglottitis Drug include Abbott, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Sanofi, Teva, GlaxoSmithKline and Roche. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epiglottitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epiglottitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Epiglottitis Drug Market Segment Percentages, by Type, 2021 (%)

• Targeted Antibiotic
• Broad-spectrum Antibiotic
• Steroid Medication

Global Epiglottitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Epiglottitis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Epiglottitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Epiglottitis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epiglottitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Epiglottitis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Merck
• AstraZeneca
• Boehringer Ingelheim
• Pfizer
• Sanofi
• Teva
• GlaxoSmithKline
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epiglottitis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epiglottitis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPIGLOTTITIS DRUG OVERALL MARKET SIZE

2.1 Global Epiglottitis Drug Market Size: 2021 VS 2028
2.2 Global Epiglottitis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epiglottitis Drug Players in Global Market
3.2 Top Global Epiglottitis Drug Companies Ranked by Revenue
3.3 Global Epiglottitis Drug Revenue by Companies
3.4 Top 3 and Top 5 Epiglottitis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epiglottitis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epiglottitis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Epiglottitis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epiglottitis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Epiglottitis Drug Market Size Markets, 2021 & 2028
  4.1.2 Targeted Antibiotic
  4.1.3 Broad-spectrum Antibiotic
  4.1.4 Steroid Medication
4.2 By Type - Global Epiglottitis Drug Revenue & Forecasts
  4.2.1 By Type - Global Epiglottitis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Epiglottitis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Epiglottitis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epiglottitis Drug Market Size, 2021 & 2028
  5.1.2 Hospitals Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Epiglottitis Drug Revenue & Forecasts
  5.2.1 By Application - Global Epiglottitis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Epiglottitis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Epiglottitis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Epiglottitis Drug Market Size, 2021 & 2028
6.2 By Region - Global Epiglottitis Drug Revenue & Forecasts
  6.2.1 By Region - Global Epiglottitis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Epiglottitis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Epiglottitis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Epiglottitis Drug Revenue, 2017-2028
  6.3.2 US Epiglottitis Drug Market Size, 2017-2028
  6.3.3 Canada Epiglottitis Drug Market Size, 2017-2028
  6.3.4 Mexico Epiglottitis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Epiglottitis Drug Revenue, 2017-2028
  6.4.2 Germany Epiglottitis Drug Market Size, 2017-2028
  6.4.3 France Epiglottitis Drug Market Size, 2017-2028
  6.4.4 U.K. Epiglottitis Drug Market Size, 2017-2028
  6.4.5 Italy Epiglottitis Drug Market Size, 2017-2028
  6.4.6 Russia Epiglottitis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Epiglottitis Drug Market Size, 2017-2028
  6.4.8 Benelux Epiglottitis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Epiglottitis Drug Revenue, 2017-2028
  6.5.2 China Epiglottitis Drug Market Size, 2017-2028
  6.5.3 Japan Epiglottitis Drug Market Size, 2017-2028
  6.5.4 South Korea Epiglottitis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Epiglottitis Drug Market Size, 2017-2028
  6.5.6 India Epiglottitis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Epiglottitis Drug Revenue, 2017-2028
  6.6.2 Brazil Epiglottitis Drug Market Size, 2017-2028
  6.6.3 Argentina Epiglottitis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epiglottitis Drug Revenue, 2017-2028
  6.7.2 Turkey Epiglottitis Drug Market Size, 2017-2028
  6.7.3 Israel Epiglottitis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Epiglottitis Drug Market Size, 2017-2028
  6.7.5 UAE Epiglottitis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Epiglottitis Drug Major Product Offerings
  7.1.4 Abbott Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Epiglottitis Drug Major Product Offerings
  7.2.4 Merck Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Epiglottitis Drug Major Product Offerings
  7.3.4 AstraZeneca Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Boehringer Ingelheim
  7.4.1 Boehringer Ingelheim Corporate Summary
  7.4.2 Boehringer Ingelheim Business Overview
  7.4.3 Boehringer Ingelheim Epiglottitis Drug Major Product Offerings
  7.4.4 Boehringer Ingelheim Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.4.5 Boehringer Ingelheim Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Epiglottitis Drug Major Product Offerings
  7.5.4 Pfizer Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Epiglottitis Drug Major Product Offerings
  7.6.4 Sanofi Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.6.5 Sanofi Key News
7.7 Teva
  7.7.1 Teva Corporate Summary
  7.7.2 Teva Business Overview
  7.7.3 Teva Epiglottitis Drug Major Product Offerings
  7.7.4 Teva Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.7.5 Teva Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Epiglottitis Drug Major Product Offerings
  7.8.4 GlaxoSmithKline Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Epiglottitis Drug Major Product Offerings
  7.9.4 Roche Epiglottitis Drug Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epiglottitis Drug Market Opportunities & Trends in Global Market
Table 2. Epiglottitis Drug Market Drivers in Global Market
Table 3. Epiglottitis Drug Market Restraints in Global Market
Table 4. Key Players of Epiglottitis Drug in Global Market
Table 5. Top Epiglottitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epiglottitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epiglottitis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epiglottitis Drug Product Type
Table 9. List of Global Tier 1 Epiglottitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epiglottitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epiglottitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epiglottitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epiglottitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epiglottitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epiglottitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epiglottitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epiglottitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epiglottitis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epiglottitis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epiglottitis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epiglottitis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epiglottitis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epiglottitis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epiglottitis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epiglottitis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epiglottitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epiglottitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epiglottitis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epiglottitis Drug Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Epiglottitis Drug Product Offerings
Table 32. Abbott Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Epiglottitis Drug Product Offerings
Table 35. Merck Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Epiglottitis Drug Product Offerings
Table 38. AstraZeneca Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Epiglottitis Drug Product Offerings
Table 41. Boehringer Ingelheim Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Epiglottitis Drug Product Offerings
Table 44. Pfizer Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Epiglottitis Drug Product Offerings
Table 47. Sanofi Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Teva Corporate Summary
Table 49. Teva Epiglottitis Drug Product Offerings
Table 50. Teva Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Epiglottitis Drug Product Offerings
Table 53. GlaxoSmithKline Epiglottitis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Epiglottitis Drug Product Offerings
Table 56. Roche Epiglottitis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Epiglottitis Drug Segment by Type in 2021
Figure 2. Epiglottitis Drug Segment by Application in 2021
Figure 3. Global Epiglottitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epiglottitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epiglottitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epiglottitis Drug Revenue in 2021
Figure 8. By Type - Global Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 12. US Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 24. China Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epiglottitis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epiglottitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Epiglottitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)